The process of finding and analyzing single nucleotide polymorphisms (SNPs) in an individual's genetic material, such as DNA, is known as SNP genotyping. SNPs are the most prevalent technology of genetic variation identified in the human genome, and they consist of a single nucleotide base (A, T, C, or G) mutation at a specific place in the DNA sequence. SNP genotyping is important in genetic research as SNPs can be linked to a variety of traits, diseases, and drug responses. Scientists can acquire insights into the underlying genetic processes driving specific traits or diseases by identifying and studying these genetic variations. SNP genotyping methods commonly used include DNA microarrays, in which SNP-containing DNA fragments are hybridized to a chip with known SNP sequences, and sequencing-based methods such as Sanger sequencing or next-generation sequencing (NGS) technologies. The results of SNP genotyping provide information about the presence or absence of specific SNP alleles in an individual's genome. This data can be used to investigate the association of specific SNPs with traits, diseases, or drug responses, as well as to conduct population genetics studies, genetic ancestry analysis, and precision medicine applications.
Market Dynamics
Launch of state-of-the-art SNP genotyping services by international organization is anticipated to support the development of the market over the analysis period. For instance, in April 2021, The Consultative Group on International Agricultural Research (CGIAR) Excellence in Breeding program, a strategic alliance of diverse contributors that supports 15 worldwide Centers, announced new low-cost, high-throughput genotyping services, positioning breeding projects in developing countries to make significant strides in delivering critical crop varieties. The Low Density SNP Genotyping Services (LDSG) offer streamlined and centralized services to breeders, as well as training and mentoring. The services provide a variety of applications that have the potential to accelerate the generation of improved varieties and improve crop breeding programs.
Key features of the study:
- This report provides in-depth analysis of the global SNP genotyping and analysis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global SNP genotyping and analysis market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Nucleome Informatics Private Limited, Azenta Life Sciences, Bio-Rad Laboratories Inc., Danaher Corporation, Douglas Scientific LLC, AllGenetics & Biology SL, Illumina Inc., Life Technologies Corp., Consultative Group on International Agricultural Research, Avance Biosciences, Genotypic Technology Pvt Ltd, Xelect Ltd, Taconic Biosciences, Inc., Luminex Corp., Promega Corporation, CD Genomics, Synbio Technologies, Thermo Fischer Scientific Inc., Sequenom, PREMIER Biosoft, Fluidigm Corporation, Novacyt, Twist Bioscience, Regeneron Pharmaceuticals, Inc, NRGene, and LGC Biosearch Technologies
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, Technology up-gradation, market expansion, and marketing tactics
- Global SNP genotyping and analysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global SNP genotyping and analysis market
Detailed Segmentation:
- Global SNP Genotyping and Analysis Market, By Technology:
- Polymerase Chain Reaction (PCR)
- Microarray
- Next-Generation Sequencing (NGS)
- Taqman Allelic Discrimination
- Pyrosequencing
- Others
- Global SNP Genotyping and Analysis Market, By Applications:
- Diagnostics & Forensics
- Pharmacogenomics
- Agricultural Biotechnology
- Breeding & Animal Livestock
- Global SNP Genotyping and Analysis Market, By Region:
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Agilent Technologies Inc.
- Hoffmann-La Roche Ltd
- Nucleome Informatics Private Limited
- Azenta Life Sciences
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Douglas Scientific LLC
- AllGenetics & Biology SL
- Illumina Inc.
- Life Technologies Corp.
- Consultative Group on International Agricultural Research
- Avance Biosciences
- Genotypic Technology Pvt Ltd
- Xelect Ltd
- Taconic Biosciences Inc.
- Luminex Corp.
- Promega Corporation
- CD Genomics
- Synbio Technologies
- Thermo Fischer Scientific Inc.
- Sequenom
- PREMIER Biosoft
- Fluidigm Corporation
- Novacyt
- Twist Bioscience
- Regeneron Pharmaceuticals, Inc
- NRGene
- LGC Biosearch Technologies
